Optimization and Functional Characterization of CAR T and CAR NK Cells

Chimeric antigen receptor (CAR) T-cell and natural killer (NK) cell therapy holds tremendous promise as a viable therapeutic option, but it also raises concerns and uncertainty when meeting the desired patient outcome and safety. Hence, robust functional and analytical characterization at every stage of CAR T/NK cell development is needed to quantify the composition, potency, and safety of these therapies. Such detailed characterization done in vitro and in vivo can help monitor and predict their behavior downstream. This webinar brings together a group of post-doctoral fellows from labs that are developing and using new tools and assays that can reliably and efficiently help characterize CAR T and NK cells.
BPS Bioscience CAR-T Cell Therapy Products: bpsbioscience.com/car-t
LinkedIn: / bps-bioscience-inc
Company Website: bpsbioscience.com/
Twitter: / bpsbioscience
Facebook: / bpsbioscience